학술논문
Neoadjuvant therapy in elderly patients receiving FOLFIRINOX or gemcitabine/nab-paclitaxel for borderline resectable or locally advanced pancreatic cancer is feasible and lead to a similar oncological outcome compared to non-aged patients – Results of the RESPECT-Study
Document Type
Article
Author
Schmid, Daniel; D'Haese, Jan G.; Böck, Stephan; Kruger, Stephan; Haas, Michael; Röder, Falk; Chiaro, Marco del; Löhr, Matthias; Tamburrino, Domenico; Masini, Gaia; Maisonneuve, Patrick; Malleo, Giuseppe; Salvia, Roberto; Charnley, Richard; Weniger, Maximilian; Moir, John; Damm, Marko; Maggino, Laura; Kordes, Maximilian; Rosendahl, Jonas; Ceyhan, Güralp O.; Schorn, Stephan
Source
In Surgical Oncology December 2020 35:285-297
Subject
Language
ISSN
0960-7404